Syndax Pharmaceuticals In... (SNDX)
NASDAQ: SNDX
· Real-Time Price · USD
9.97
-0.28 (-2.73%)
At close: Jun 16, 2025, 3:59 PM
9.99
0.15%
After-hours: Jun 16, 2025, 05:45 PM EDT
-2.73% (1D)
| Bid | 9.99 |
| Market Cap | 858.32M |
| Revenue (ttm) | 43.72M |
| Net Income (ttm) | -331.2M |
| EPS (ttm) | -3.85 |
| PE Ratio (ttm) | -2.59 |
| Forward PE | -3.95 |
| Analyst | Buy |
| Ask | 10.55 |
| Volume | 1,069,492 |
| Avg. Volume (20D) | 2,168,560 |
| Open | 10.00 |
| Previous Close | 10.25 |
| Day's Range | 9.77 - 10.21 |
| 52-Week Range | 8.58 - 25.07 |
| Beta | 0.74 |
About SNDX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SNDX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SNDX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+7.47%
Syndax Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
3 months ago
-1.02%
Syndax Pharmaceuticals shares are trading lower after the company reported Q4 financial results and missed its EPS and sales estimate.
1 month ago · seekingalpha.com
Syndax Pharmaceuticals, Inc. (SNDX) Q1 2025 Earnings Call TranscriptSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX ) Q1 2025 Earnings Conference Call May 5, 2025 4:30 PM ET Company Participants Sharon Klahre - Head of IR Michael Metzger - Chief Executive Officer and Direct...
